{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:43:24Z","timestamp":1789177404341,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41372-024-01922-6","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T12:01:56Z","timestamp":1711022516000},"page":"1780-1785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Use of urine neutrophil gelatinase-associated lipocalin for nephrotoxic medication acute kidney injury screening in neonates"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4880-9792","authenticated-orcid":false,"given":"Cara L.","family":"Slagle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Hemmelgarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2848-1048","authenticated-orcid":false,"given":"Hailey W.","family":"Gavigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli A.","family":"Krallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"1922_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3109\/14767058.2013.860522","volume":"27","author":"ET Rhone","year":"2014","unstructured":"Rhone ET, Carmody JB, Swanson JR, Charlton JR. Nephrotoxic medication exposure in very low birth weight infants. J Matern Fetal Neonatal Med. 2014;27:1485\u201390.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1922_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s41372-023-01684-7","volume":"43","author":"HJ Steflik","year":"2023","unstructured":"Steflik HJ, Charlton JR, Briley M, Selewski DT, Gist KM, Hanna MH, et al. Neonatal nephrotoxic medication exposure and early acute kidney injury: results from the AWAKEN study. J Perinatol. 2023;43:1029\u201337.","journal-title":"J Perinatol"},{"key":"1922_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.kint.2019.10.015","volume":"97","author":"SL Goldstein","year":"2020","unstructured":"Goldstein SL, Dahale D, Kirkendall ES, Mottes T, Kaplan H, Muething S, et al. A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children. Kidney Int. 2020;97:580\u20138.","journal-title":"Kidney Int"},{"key":"1922_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jpeds.2019.08.046","volume":"215","author":"C Stoops","year":"2019","unstructured":"Stoops C, Stone S, Evans E, Dill L, Henderson T, Griffin R, et al. Baby NINJA (nephrotoxic injury negated by just-in-time action): reduction of nephrotoxic medication-associated acute kidney injury in the neonatal intensive care unit. J Pediatr. 2019;215:223\u20138.e6.","journal-title":"J Pediatr"},{"key":"1922_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.17219\/acem\/32065","volume":"25","author":"N Jakacka","year":"2016","unstructured":"Jakacka N, Snarski E, Mekuria S. Prevention of iatrogenic anemia in critical and neonatal care. Adv Clin Exp Med. 2016;25:191\u20137.","journal-title":"Adv Clin Exp Med"},{"key":"1922_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00467-012-2185-x","volume":"27","author":"D Askenazi","year":"2012","unstructured":"Askenazi D. Are we ready for the clinical use of novel acute kidney injury biomarkers? Pediatr Nephrol. 2012;27:1423\u20135.","journal-title":"Pediatr Nephrol"},{"key":"1922_CR7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00467-020-04917-5","volume":"36","author":"HW Gavigan","year":"2021","unstructured":"Gavigan HW, Slagle CL, Krallman KA, Poindexter BB, Hooper DK, Goldstein SL. Blood transfusion rates in Baby NINJA (nephrotoxic injury negated by just-in-time action)-a single-center experience. Pediatr Nephrol. 2021;36:1901\u20135.","journal-title":"Pediatr Nephrol"},{"key":"1922_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jpeds.2011.05.045","volume":"159","author":"DJ Askenazi","year":"2011","unstructured":"Askenazi DJ, Montesanti A, Hundley H, Koralkar R, Pawar P, Shuaib F, et al. Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. J Pediatr. 2011;159:907\u201312.e1.","journal-title":"J Pediatr"},{"key":"1922_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jpeds.2012.02.007","volume":"161","author":"DJ Askenazi","year":"2012","unstructured":"Askenazi DJ, Koralkar R, Hundley HE, Montesanti A, Parwar P, Sonjara S, et al. Urine biomarkers predict acute kidney injury in newborns. J Pediatr. 2012;161:270\u20135.","journal-title":"J Pediatr"},{"key":"1922_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jpeds.2021.07.041","volume":"238","author":"CL Slagle","year":"2021","unstructured":"Slagle CL, Goldstein SL, Gavigan HW, Rowe JA, Krallman KA, Kaplan HC, et al. Association between elevated urine neutrophil gelatinase-associated lipocalin and postoperative acute kidney injury in neonates. J Pediatr. 2021;238:193\u2013201.e2.","journal-title":"J Pediatr"},{"key":"1922_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jpeds.2021.08.090","volume":"241","author":"J Rumpel","year":"2022","unstructured":"Rumpel J, Spray BJ, Chock VY, Kirkley MJ, Slagle CL, Frymoyer A, et al. Urine biomarkers for the assessment of acute kidney injury in neonates with hypoxic ischemic encephalopathy receiving therapeutic hypothermia. J Pediatr. 2022;241:133\u201340.e3.","journal-title":"J Pediatr"},{"key":"1922_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2215\/CJN.04010907","volume":"3","author":"M Bennett","year":"2008","unstructured":"Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol. 2008;3:665\u201373.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1922_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1203\/PDR.0b013e318181b3b2","volume":"64","author":"AP Lavery","year":"2008","unstructured":"Lavery AP, Meinzen-Derr JK, Anderson E, Ma Q, Bennett MR, Devarajan P, et al. Urinary NGAL in premature infants. Pediatr Res. 2008;64:423\u20138.","journal-title":"Pediatr Res"},{"key":"1922_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0035-1563714","volume":"33","author":"D Jansen","year":"2016","unstructured":"Jansen D, Peters E, Heemskerk S, Koster-Kamphuis L, Bouw MP, Roelofs HM, et al. Tubular injury biomarkers to detect gentamicin-induced acute kidney injury in the neonatal intensive care unit. Am J Perinatol. 2016;33:180\u20137.","journal-title":"Am J Perinatol"},{"key":"1922_CR15","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00467-020-04898-5","volume":"36","author":"SL Goldstein","year":"2021","unstructured":"Goldstein SL, Krallman KA, Schmerge A, Dill L, Gerhardt B, Chodaparavu P, et al. Urinary neutrophil gelatinase-associated lipocalin rules out nephrotoxic acute kidney injury in children. Pediatr Nephrol. 2021;36:1915\u201321.","journal-title":"Pediatr Nephrol"},{"key":"1922_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.2215\/CJN.13381215","volume":"11","author":"DJ Askenazi","year":"2016","unstructured":"Askenazi DJ, Koralkar R, Patil N, Halloran B, Ambalavanan N, Griffin R. Acute kidney injury urine biomarkers in very low-birth-weight infants. Clin J Am Soc Nephrol. 2016;11:1527\u201335.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1922_CR17","first-page":"167","volume":"31","author":"Y Tabel","year":"2014","unstructured":"Tabel Y, Elmas A, Ipek S, Karadag A, Elmas O, Ozyalin F. Urinary neutrophil gelatinase-associated lipocalin as an early biomarker for prediction of acute kidney injury in preterm infants. Am J Perinatol. 2014;31:167\u201374.","journal-title":"Am J Perinatol"},{"key":"1922_CR18","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1542\/peds.2013-0794","volume":"132","author":"SL Goldstein","year":"2013","unstructured":"Goldstein SL, Kirkendall E, Nguyen H, Schaffzin JK, Bucuvalas J, Bracke T, et al. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics. 2013;132:e756\u201367.","journal-title":"Pediatrics"},{"key":"1922_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.clp.2014.05.001","volume":"41","author":"JG Jetton","year":"2014","unstructured":"Jetton JG, Askenazi DJ. Acute kidney injury in the neonate. Clin Perinatol. 2014;41:487\u2013502.","journal-title":"Clin Perinatol"},{"key":"1922_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00134-014-3391-8","volume":"40","author":"DT Selewski","year":"2014","unstructured":"Selewski DT, Cornell TT, Heung M, Troost JP, Ehrmann BJ, Lombel RM, et al. Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med. 2014;40:1481\u20138.","journal-title":"Intensive Care Med"},{"key":"1922_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/qhc.12.6.458","volume":"12","author":"JC Benneyan","year":"2003","unstructured":"Benneyan JC, Lloyd RC, Plsek PE. Statistical process control as a tool for research and healthcare improvement. Qual Saf Health Care. 2003;12:458\u201364.","journal-title":"Qual Saf Health Care"},{"key":"1922_CR22","volume-title":"R: A language and environment for statistical computing","author":"R Developement Core Team.","year":"2020","unstructured":"R Developement Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020."},{"key":"1922_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.hoc.2019.01.013","volume":"33","author":"IMC Ree","year":"2019","unstructured":"Ree IMC, Lopriore E. Updates in neonatal hematology: causes, risk factors, and management of anemia and thrombocytopenia. Hematol Oncol Clin North Am 2019;33:521\u201332.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1922_CR24","doi-asserted-by":"publisher","unstructured":"Stoops C, Gavigan H, Krallman K, Anderson N, Griffin R, Slagle C, et al. The Utility of Urinary NGAL as an alternative for serum creatinine to detect acute kidney injury in infants exposed to nephrotoxic medications in the neonatal intensive care unit. Neonatology. 2023:1\u201310. https:\/\/doi.org\/10.1159\/000535322. Epub ahead of print.","DOI":"10.1159\/000535322"},{"key":"1922_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1203\/PDR.0b013e3182275164","volume":"70","author":"DJ Askenazi","year":"2011","unstructured":"Askenazi DJ, Koralkar R, Levitan EB, Goldstein SL, Devarajan P, Khandrika S, et al. Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr Res. 2011;70:302\u20136.","journal-title":"Pediatr Res"},{"key":"1922_CR26","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jacc.2010.11.051","volume":"57","author":"M Haase","year":"2011","unstructured":"Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011;57:1752\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"1922_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrneph.2012.197","volume":"8","author":"M Haase","year":"2012","unstructured":"Haase M, Kellum JA, Ronco C. Subclinical AKI\u2013an emerging syndrome with important consequences. Nat Rev Nephrol. 2012;8:735\u20139.","journal-title":"Nat Rev Nephrol"},{"key":"1922_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000525221","volume":"12","author":"M Marcello","year":"2022","unstructured":"Marcello M, Virzi GM, Mucino-Bermejo MJ, Milan Manani S, Giavarina D, Salvador L, et al. Subclinical AKI and clinical outcomes in elderly patients undergoing cardiac surgery: diagnostic utility of NGAL versus standard creatinine increase criteria. Cardiorenal Med. 2022;12:94\u2013105.","journal-title":"Cardiorenal Med"},{"key":"1922_CR29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1164\/rccm.202006-2239ED","volume":"202","author":"JL Koyner","year":"2020","unstructured":"Koyner JL. Subclinical acute kidney injury is acute kidney injury and should not be ignored. Am J Respir Crit Care Med. 2020;202:786\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1922_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12887-016-0761-0","volume":"17","author":"A Sellmer","year":"2017","unstructured":"Sellmer A, Bech BH, Bjerre JV, Schmidt MR, Hjortdal VE, Esberg G, et al. Urinary neutrophil gelatinase-associated lipocalin in the evaluation of patent ductus arteriosus and AKI in very preterm neonates: a cohort study. BMC Pediatr. 2017;17:7.","journal-title":"BMC Pediatr"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-024-01922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-024-01922-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-024-01922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:02:17Z","timestamp":1732849337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-024-01922-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1922"],"URL":"https:\/\/doi.org\/10.1038\/s41372-024-01922-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3408480\/v1","asserted-by":"object"}]},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Cara Slagle, MD is a consultant for AM Pharma and Medtronic and has received honorariums from Medtronic, the University of Alabama, and the AKI Critical Care Foundation, all unrelated to the work above. Stuart Goldstein, MD and Cincinnati Children\u2019s Hospital receive royalties from Vigilanz Corporation (Minneapolis, MN) for the NINJA application licensed to Vigilanz from Cincinnati Children\u2019s Hospital Medical Center. Dr. Goldstein consults and receives research funding from BioPorto Diagnostics, Inc, which markets The ProNephroAKI NGAL Test\u2122.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}